SCIE期刊HIV Research & Clinical Practice 2024/2025影响因子:1.742 (HIV RES CLIN PRACT) (2578-7489). (PHARMACOLOGY & PHARMACY)(

显示全部楼层 · 发表于 2025-3-25 05:12:18

Submitted on: 03 September 2021. Revised on: 27 October 2021. Accepted on: 22 December 2021. ___________________HIV Research & Clinical Practice

显示全部楼层 · 发表于 2025-3-25 07:43:18

Submitted on: 04 March 2011. Revised on: 27 May 2011. Accepted on: 21 June 2011. ___________________HIV Research & Clinical Practice

显示全部楼层 · 发表于 2025-3-25 12:07:09

Submitted on: 15 February 2017. Revised on: 17 April 2017. Accepted on: 01 June 2017. ___________________HIV Research & Clinical Practice

显示全部楼层 · 发表于 2025-3-25 18:15:00

显示全部楼层 · 发表于 2025-3-25 20:02:05

显示全部楼层 · 发表于 2025-3-26 01:21:53

显示全部楼层 · 发表于 2025-3-26 07:14:20

显示全部楼层 · 发表于 2025-3-26 11:15:30

Submitted on: 28 March 2013. Revised on: 26 May 2013. Accepted on: 24 July 2013. ___________________HIV Research & Clinical Practice

显示全部楼层 · 发表于 2025-3-26 13:52:14

Submitted on: 07 March 2019. Revised on: 07 May 2019. Accepted on: 10 June 2019. ___________________HIV Research & Clinical Practice

显示全部楼层 · 发表于 2025-3-26 17:01:57

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	吾爱论文网	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-10 23:54
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved